Wagner R - Search Results

1

Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.

Kibler KV, Asbach B, Perdiguero B, García-Arriaza J, Yates NL, Parks R, Stanfield-Oakley S, Ferrari G, Montefiori DC, Tomaras GD, Roederer M, Foulds KE, Forthal DN, Seaman MS, Self S, Gottardo R, Phogat S, Tartaglia J, Barnett S, Cristillo AD, Weiss D, Galmin L, Ding S, Heeney JL, Esteban M, Wagner R, Pantaleo G, Jacobs BL. Kibler KV, et al. Among authors: wagner r. J Virol. 2019 Jan 17;93(3):e01513-18. doi: 10.1128/JVI.01513-18. Print 2019 Feb 1. J Virol. 2019. PMID: 30429340 Free PMC article.

2

Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.

Wagner R, Fliessbach H, Wanner G, Motz M, Niedrig M, Deby G, von Brunn A, Wolf H. Wagner R, et al. Arch Virol. 1992;127(1-4):117-37. doi: 10.1007/BF01309579. Arch Virol. 1992. PMID: 1456888

3

Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses.

Wagner R, Böltz T, Deml L, Modrow S, Wolf H. Wagner R, et al. J Gen Virol. 1993 Jul;74 ( Pt 7):1261-9. doi: 10.1099/0022-1317-74-7-1261. J Gen Virol. 1993. PMID: 7687647 Free article.

4

Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).

Osterrieder N, Wagner R, Brandmüller C, Schmidt P, Wolf H, Kaaden OR. Osterrieder N, et al. Among authors: wagner r. Virology. 1995 Apr 20;208(2):500-10. doi: 10.1006/viro.1995.1181. Virology. 1995. PMID: 7747423 Free article.

5

Identification of a region in the Pr55gag-polyprotein essential for HIV-1 particle formation.

von Poblotzki A, Wagner R, Niedrig M, Wanner G, Wolf H, Modrow S. von Poblotzki A, et al. Among authors: wagner r. Virology. 1993 Apr;193(2):981-5. doi: 10.1006/viro.1993.1210. Virology. 1993. PMID: 8460500

6

Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles.

Wagner R, Deml L, Schirmbeck R, Niedrig M, Reimann J, Wolf H. Wagner R, et al. Virology. 1996 Jun 1;220(1):128-40. doi: 10.1006/viro.1996.0293. Virology. 1996. PMID: 8659105 Free article.

7

A recombinant HIV-1 virus-like particle vaccine: from concepts to a field study.

Wagner R, Deml L, Teeuwsen V, Heeney J, Yiming S, Wolf H. Wagner R, et al. Antibiot Chemother (1971). 1996;48:68-83. doi: 10.1159/000425160. Antibiot Chemother (1971). 1996. PMID: 8726508 Review. No abstract available.

8

Safety and immunogenicity of recombinant human immunodeficiency virus-like particles in rodents and rhesus macaques.

Wagner R, Deml L, Notka F, Wolf H, Schirmbeck R, Reimann J, Teeuwsen V, Heeney J. Wagner R, et al. Intervirology. 1996;39(1-2):93-103. doi: 10.1159/000150480. Intervirology. 1996. PMID: 8957675 Review.

9

Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.

Deml L, Kratochwil G, Osterrieder N, Knüchel R, Wolf H, Wagner R. Deml L, et al. Among authors: wagner r. Virology. 1997 Aug 18;235(1):10-25. doi: 10.1006/viro.1997.8669. Virology. 1997. PMID: 9300033 Free article.

10

Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.

Deml L, Schirmbeck R, Reimann J, Wolf H, Wagner R. Deml L, et al. Among authors: wagner r. Virology. 1997 Aug 18;235(1):26-39. doi: 10.1006/viro.1997.8668. Virology. 1997. PMID: 9300034 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,010 results

Search Page